This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Johnson, J. Articles by Miller, A. Search for Related Content PubMed PubMed Citation Articles by Johnson, J. Articles by Miller, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Bone Cancer Pain Palliative Care Hazardous Substances DB CHOLINE BITARTRATE CHOLINE CHLORIDE Social Bookmarking                         What's this?

The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study

Shropshire and Mid Wales Hospice, Bicton Heath, Shrewsbury

AJ Miller

Napp Laboratories, Cambridge Science Park, Cambridge

Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo. Assessments were made prior to and at one, two, three and four hours after dosing.

Bone pain caused by metastatic cancer was significantly relieved one hour after the administration of 1500 mg CMT (p = 0.04). At all four time points the pain was less than baseline with CMT and at three time points greater than baseline with placebo but these results did not reach statistical significance. The summed pain intensity difference for patients was greater with CMT than with placebo, but this also did not reach significance. The incidence of volunteered side-effects was similar for both treatments. The results suggest that a nonacetylating, nonsteroidal anti-inflammatory drug may have a role complementary to that of an opioid in the management of metastatic bone pain.

Key Words: anti-inflammatory agents • nonsteroidal • bone neoplasms • pain • palliative treatment

Palliative Medicine, Vol. 8, No. 2, 129-135 (1994)
DOI: 10.1177/026921639400800206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. SPINK, S. BAHN, and R. GLICKMAN Clinical implications of cyclo-oxygenase-2 inhibitors for acute dental pain management: Benefits and risks J Am Dent Assoc, October 1, 2005; 136(10): 1439 - 1448. [Abstract] [Full Text] [PDF]